Lazard Asset Management
GH icon

Lazard Asset Management’s Guardant Health GH Stock Holding History

Lazard Asset Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.18M Sell
21,165
-3,254
-13% -$354K ﹤0.01% 778
2026
Q1 		$2.26M Sell
24,419
-6,166
-20% -$619K ﹤0.01% 834
2025
Q4 		$3.12M Sell
30,585
-19,925
-39% -$1.78M 0.01% 698
2025
Q3 		$3.16M Buy
50,510
+20,855
+70% +$1.13M ﹤0.01% 723
2025
Q2 		$1.54M Sell
29,655
-1,151
-4% -$51.4K ﹤0.01% 1106
2025
Q1 		$1.31M Sell
30,806
-18,825
-38% -$812K ﹤0.01% 1107
2024
Q4 		$1.52M Sell
49,631
-69,620
-58% -$1.96M ﹤0.01% 978
2024
Q3 		$2.73M Sell
119,251
-17,018
-12% -$482K ﹤0.01% 795
2024
Q2 		$3.94M Sell
136,269
-1,498
-1% -$34.9K ﹤0.01% 737
2024
Q1 		$2.84M Sell
137,767
-12,370
-8% -$265K ﹤0.01% 784
2023
Q4 		$4.06M Sell
150,137
-6,154
-4% -$161K 0.01% 723
2023
Q3 		$4.63M Sell
156,291
-40,330
-21% -$1.42M 0.01% 709
2023
Q2 		$7.04M Sell
196,621
-197
-0.1% -$5.66K 0.01% 629
2023
Q1 		$4.61M Buy
196,818
+42,751
+28% +$1.22M 0.01% 743
2022
Q4 		$4.19M Sell
154,067
-64,244
-29% -$2.94M 0.01% 757
2022
Q3 		$11.8M Buy
218,311
+8,183
+4% +$420K 0.02% 537
2022
Q2 		$8.48M Buy
210,128
+99,893
+91% +$4.95M 0.01% 620
2022
Q1 		$7.3M Buy
110,235
+26,217
+31% +$1.79M 0.01% 684
2021
Q4 		$8.4M Buy
84,018
+43,054
+105% +$4.45M 0.01% 676
2021
Q3 		$5.12M Buy
40,964
+7,729
+23% +$918K 0.01% 759
2021
Q2 		$4.13M Buy
33,235
+32,717
+6,316% +$4.4M ﹤0.01% 749
2021
Q1 		$79K Sell
518
-68
-12% -$10.3K ﹤0.01% 1261
2020
Q4 		$75K Buy
+586
New +$67.4K ﹤0.01% 1261
2020
Q3 		– Sell
-47
Closed -$3K – 1654
2020
Q2 		$3K Buy
+47
New +$3.79K ﹤0.01% 1543

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Lazard Asset Management's GH Position: Q2 2026 in Review

Lazard Asset Management reduced its Guardant Health (GH) stake by 13% in Q2 2026, selling an estimated $354K and leaving 21,165 shares worth $3.18M. The position accounts for ﹤0.01% of the portfolio, ranked #778.

Lazard Asset Management first reported a position in GH in Q2 2020 and has held it in 24 quarters since. The position peaked at $11.8M in Q3 2022. 599 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Lazard Asset Management held 21,165 shares of Guardant Health worth $3.18M as of Q2 2026.
  • Lazard Asset Management sold 3,254 Guardant Health shares in Q2 2026, an estimated $354K.
  • Guardant Health made up ﹤0.01% of Lazard Asset Management's portfolio in Q2 2026, its #778 holding.
  • Lazard Asset Management first reported a position in Guardant Health in Q2 2020 and has held it in 24 quarters since.
  • Lazard Asset Management's Guardant Health position peaked at $11.8M in Q3 2022.
  • 599 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.